What is Medline, Inc. 's D&A?

Medline, Inc. (MDLN) reported D&A of $254M in Q1 2026.

How has Medline, Inc. 's D&A changed year-over-year?

Medline, Inc. 's D&A increased by 2.8% year-over-year, from $247M to $254M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Medline, Inc. MDLN D&A

D&A at other companies

Baxter InternationalBAX

$237M-4.0%

Henry ScheinHSIC

$81M+11.0%

Merit Medical SystemsMMSI

$30.5M+4.1%

CorMedixCRMD

$10.54M+20,197%

NovantaNOVT

$5.77M+4.0%

SolventumSOLV

——

Other financials

Income statement

See full

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

See full

Cash & equivalents$2.2B+166%

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

See full

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation

See full

Market cap$33.35B+17.5%

Enterprise value$43.67B—

P/E39.6×—

P/S1.3×—

Profitability

See full

Gross margin27.4%+1.5pp

Operating margin8.5%+2.3pp

Net margin4.6%+2.7pp

FCF margin6.4%+0.5pp

Returns & leverage

See full

Return on equity7.7%—

Debt / equity1.1×—

Current ratio4.4×—

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medline, Inc. 's D&A?: Medline, Inc. (MDLN) reported D&A of $254M in Q1 2026.
How has Medline, Inc. 's D&A changed year-over-year?: Medline, Inc. 's D&A increased by 2.8% year-over-year, from $247M to $254M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.